Galman C, Angelin B, Rudling M Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med. 2011 Dec;270(6):580-8. doi: 10.1111/j.1365-2796.2011.02466.x. Epub 2011 Nov 2.
Hart RA, Woo SL, Newton PO Ultrastructural morphometry of anterior cruciate and medial collateral ligaments: an experimental study in rabbits. J Orthop Res. 1992 Jan;10(1):96-103. doi: 10.1002/jor.1100100112.
Hofmann AF The enterohepatic circulation of bile acids in mammals: form and functions. Front Biosci (Landmark Ed). 2009 Jan 1;14(7):2584-98. doi: 10.2741/3399.
Kuipers F, Bloks VW, Groen AK Beyond intestinal soap--bile acids in metabolic control. Nat Rev Endocrinol. 2014 Aug;10(8):488-98. doi: 10.1038/nrendo.2014.60. Epub 2014 May 13.
McEwan HP Treatment of severe toxaemia of pregnancy. Lancet. 1972 Feb 12;1(7746):374. doi: 10.1016/s0140-6736(72)92862-0. No abstract available.
Mraz M, Lacinova Z, Kavalkova P, Haluzikova D, Trachta P, Drapalova J, Hanusova V, Haluzik M Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment. Physiol Res. 2011;60(4):627-36. doi: 10.33549/physiolres.932099. Epub 2011 May 16.
Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg. 1996 Oct;83(10):1345-9. doi: 10.1002/bjs.1800831007.
Schaap FG, Trauner M, Jansen PL Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):55-67. doi: 10.1038/nrgastro.2013.151. Epub 2013 Aug 27.
Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology. 2009 Apr;49(4):1228-35. doi: 10.1002/hep.22771.
Wells CL, Jechorek RP, Erlandsen SL Inhibitory effect of bile on bacterial invasion of enterocytes: possible mechanism for increased translocation associated with obstructive jaundice. Crit Care Med. 1995 Feb;23(2):301-7. doi: 10.1097/00003246-199502000-00016.
Zweers SJ, Booij KA, Komuta M, Roskams T, Gouma DJ, Jansen PL, Schaap FG The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology. 2012 Feb;55(2):575-83. doi: 10.1002/hep.24702. Epub 2011 Dec 19.
FGF19 in Obstructive Cholestasis: "Unveil the Signal"
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
